Avantax Advisory Services, Inc. Horizon Therapeutics Public LTD CO Transaction History

Avantax Advisory Services, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	SELL	$107.32 - $113.5 $3,112 - $3,291	-29 Reduced 1.23%	2,329 $254,000
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $147,115 - $268,340	2,358 New	2,358 $268,000
Q2 2021 Jul 29, 2021	SELL	$86.24 - $95.92 $410,761 - $456,866	-4,763 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $342,126 - $454,771	4,763 New	4,763 $438,000
Q4 2020 Jan 22, 2021	SELL	$67.0 - $84.39 $710,401 - $894,787	-10,603 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$55.23 - $79.93 $585,603 - $847,497	10,603 New	10,603 $824,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Advisory Services, Inc. with notifications on news.